I'm sure we'll all live while we wait longer, but I do

New Post Public Reply Private Reply Replies (4) Message Board
Buildit
400
I'm sure we'll all live while we wait longer, but I do think this is a botched effort at messaging and managing expectations. All we have to go on is what Joe tells us.

Here is what he told us on the call (one or two in the middle are from Rich). Wait until you get to the last two, then tell me if my expectations of getting information in 7-10 days were misplaced or if I was misled. And feel free to look these up in the transcript, but they're all copy and paste quotes:

1) The spleens were collected and shipped to CTL for the T-Cell analysis and the serum was delivered--they were shipped yesterday and delivered today, the serum analysis for the neutralizing antibody studies that will be done next week. And within ten days or so, we'll have an answer whether we have this complete vaccine.

2) ...the experimental piece of this is will we generate the neutralizing antibody response that we're looking for from the complete vaccine? And we'll have that answer within a few days. And at that point, we'll know whether we have the overall complete vaccine or whether we'll be pushed towards a universal booster for long-term memory...

3) But it's important to note that we can respond quickly, and we can target the immune response specifically to whatever targets we're looking for, whether it's a variant or the source coronavirus that we have now. So, that's continuing and we're looking forward to those results in a few days.

4) So, I thought that was very important to add and I’m very excited about the next ten days; we have the one last big test, once that's complete, and if it's anything like all of our other testing, we'll move right into filing our IND, and we'll get the rest of the work done.

5) And we're really excited about this program and within the next ten days, that will really tell the story and we get the last set of results, and they're good, we have a complete vaccine where not a lot of other people can say that.

6) So, we're excited about that and we're hoping that once we come out with these results next week--ten days--which is the final, and get that IND approved...

7) So, I guess that's it with the questions. I just want to thank everybody for attending the call, and I'd just like to add that over the next seven to ten days on our last test we will have, we will alert everybody to that final result which will give us what we believe is a complete vaccine, which is safe, effective, and with long-term memory. And immediately thereafter, our IND will be filed, and we'll get into clinic for this complete vaccine. (Bolding mine)

8) So, we're very excited about the future, we thank everybody for the call. Be on the lookout in the next week to ten days for our results. If it's good, we'll be able to make claims that not a lot of other companies can at this point.


Joe, you know who I am, and I've given you my number numerous times. Please feel free to call me and discuss how I was supposed to interpret "over the next seven to ten days on our last test we will have, we will alert everybody to that final result" and "Be on the lookout in the next week to ten days for our results" to mean anything other than I should know what the test results are in the next 7-10 days.

It's right there in black and white. Clear as a bell.

This is simply unacceptable. You need to deliver an update with some sort of clarification on the timelines by the end of next week. We deserve that.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 5

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Recent Developments in Consumer Technology and Trade Relations

Updated Category News Views 245

U.S.-China Trade Dynamics Chinese President Xi Jinping has emphasized ongoing developments in the trade relations between the U.S. and China. In a recent communication with President Donald Trump, both leaders discussed potential measures that could foster a positive trajectory for trade negotiations. Amid these discussions, reports surfaced that the U.S. is contemplating...

Continue Reading
HealthEquity Amid Allegations: An Investor's Guide to HQY

Updated Category News Views 244

Understanding the Investigation into HealthEquity, Inc. Pomerantz LLP is currently conducting a thorough investigation into the claims made by investors of HealthEquity, Inc. This action highlights potential concerns regarding the company’s business practices and the conduct of certain officers and directors. What Triggered the Investigation? The investigation centers...

Continue Reading
PetVivo AI Unveils Innovative Platform to Cut Client Costs

Updated Category News Views 147

Revolutionizing Veterinary Practices with AI PetVivo AI, Inc. is taking the veterinary world by storm with the introduction of PetVivo.ai, an innovative artificial intelligence platform aimed at transforming the pet care sector. With the pet care industry experiencing exponential growth—surpassing $150 billion—this platform promises to decrease client acquisition...

Continue Reading
Avery Dennison's Earnings Anticipation: What Investors Should Know

Updated Category News Views 126

Upcoming Earnings Report for Avery Dennison Avery Dennison (NYSE: AVY) is gearing up for a significant quarter, with expectations heightened ahead of its earnings announcement. Investors are eagerly awaiting the results, which could reveal crucial insights into the company's current performance and future direction. Analysts' Expectations Market analysts predict that...

Continue Reading
Understanding Recent Trends in HDFC Bank Ltd's Short Interest

Updated Category News Views 169

Recent Developments in HDFC Bank Ltd's Short Interest HDFC Bank Ltd (NYSE:HDB) has recently experienced a notable shift in its short interest. According to the latest information, short interest as a percentage of float has decreased by 3.23%. Currently, there are 15.25 million shares sold short, representing 0.3% of the available regular shares for trading. This change...

Continue Reading